PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Biological Drugs Market .pdf



Original filename: Biological Drugs Market.pdf
Author: user

This PDF 1.5 document has been generated by Microsoft® Word 2010, and has been sent on pdf-archive.com on 04/05/2018 at 09:07, from IP address 116.75.x.x. The current document download page has been viewed 237 times.
File size: 326 KB (8 pages).
Privacy: public file




Download original PDF file









Document preview


Biological Drugs Market: Global Industry Analysis, Trends, Market Size &
Forecasts up to 2023
Infinium Global Research

A latest report has been added to the wide database of Biological Drug Market by Infinium Global Research. This report
studies the Diabetes Drug Therapy Market by Product Type (therapeutic protein -levemir, neulasta, eylea, novolog, enbrel,
avonex, neupogen, humalog, victoza, lantus, epogen, aranesp; monoclonal antibody - avastin, humira, remicade; vaccine gardasil, prenvar 13, fluzone) market status and outlook of global and major regions, from manufacturers, and end industries.
The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the
values for the next six years. Diabetes Drug Therapy Market provides opportunities in micro markets for stakeholders to
invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies
in the Diabetes Drug Therapy Market. According to the report the Global Biological Drugs Market is projected to grow at a
CAGR between 10.0% to 10.5% in terms of value over the period of 2017-2023. Increasing geriatric population in the world is
driving the growth of the biological drugs market, as there is increasing requirement for effective medicines for various
illnesses affecting old age people. Increasing number of patients with cancer, diabetes and other major chronic illnesses are
expected to drive the growth of the biological drugs market during the forecast period. Biological drugs are more effective
than respective chemical and other alternative medicines for several complex chronic illnesses. Hence, the biological drugs
market is anticipated to attain significant growth in demand, despite the high cost of the products. The investments in
research and development of biological drugs and innovation in manufacturing of biologics are anticipated to yield more
products during the forecast period. Moreover, the promotional activities by various health organisations and policies by
governments to make biological drugs affordable for the treatment of chronic illnesses are expected to enhance the growth
of the global biological drugs market. Furthermore, the health regulatory policies with restrictions on chemical drugs with
severe side effects and the improving healthcare services in various countries are expected to enhance the growth of the
global biological drugs market.
The expiry of patents of many biological drugs provides opportunity for low cost biosimilars and other biological
pharmaceutical companies to manufacture alternative drugs. Higher cost of manufacturing and the higher selling price of
biological drugs give biosimilars and other alternatives the price advantage. Severe side effects related to injectable type of
biological drugs is a restraint to the expansion of the market. The complexity of manufacturing of biological drugs is a major
challenge for the global biological manufacturers, especially in the developing and least developed countries, where it is
difficult to maintain both the controlled environment for manufacturing and quality control. Moreover, lack of proper
refrigeration or environment controllable transportation facilities hinder the uniform quality of biological drugs in different
regions, due to contamination at different stages. However, the need for effective medicines for illnesses like cancer,
Infinium Global Research

autoimmune diseases, and other chronic illnesses with minimal side effects when compared to chemical drugs is expected to
provide opportunities for major players in the biological drugs market during the forecast period.
Segments Covered:
The report segments the global biological drugs market by product and region. On the basis of product, the market is
segmented as protein therapy, mAb therapy and vaccines. Monoclonal antibodies segment is expected to sustain a major
share in the global biological drugs market during the forecast period. Among protein therapy segment, Enbrel is expected to
attain more demand with fastest growth rate during the forecast period. Among the vaccines, the demand for Prevnar 13 is
anticipated to grow significantly during the forecast period.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the
World. North America dominates the global biological drugs market with a major share. Increasing technological
advancements, favorable regulatory policies and increasing awareness about the biological due to intervention of
governments and other agencies are the major factors that drive the growth of the North American biological drugs market.
Moreover, the increasing demand for biological drugs for the treatment of chronic illnesses such as cancer and diabetes is
anticipated to drive the growth of the North American biological market during the forecast period. The presence of large
geriatric population in the countries such as Germany and United Kingdom drive the growth of European biological drugs
market. Furthermore, presence of top quality research and development infrastructure due to the partnerships between
research institutes and manufacturing companies and increased funding from private-public initiatives drives the growth of
the European market. The demand for alternative drugs for the treatment of chronic illnesses from the emerging nations in
the Eastern Europe is anticipated to enhance the growth of the European biological drugs market.
Presence of large population with chronic illnesses, initiatives from governments to promote biologics, high investments in
biologic drug manufacturing facilities, encouragement for biotech companies and research initiatives are major factors that
drive the Asian biological drugs market. Moreover, the low manufacturing cost and the availability of low cost labor is
expected to enhance the growth of the Asian biological drugs market, as it could attract more established players in the
global market to Asia. The presence of good regulatory frameworks for biologics, increasing instances of chronical illnesses
and encouragement from governments to promote manufacturing of drugs to in the region to make treatments affordable
are the major factors that drive the Latin American biological drugs market. Substandard biological drugs due to the absence
Infinium Global Research

of stringent regulatory frameworks, presence of biosimilars and other alternatives are the major restraints for African
biological drugs market. However, with the Ebola outbreak in recent past and the presence of large number of patients with
AIDS and other chronic illnesses provide positive outlook for the growth of the biological drugs market in Africa. Presence of
numerous patients with diabetes, rheumatoid arthritis and other chronic illnesses and availability of good healthcare systems
are expected to drive the biological drugs market in the Middle East during the forecast period.
Companies Profiled:
AbbVieInc,
Amgen Inc,
Bristol-Myers Squibb,
Biogen Idec,
Hoffman-La Roche AG,
Johnson & Johnson,
Lilly,
Merck & Co Inc,
Novartis,
Novo Nordisk,
Pfizer Inc,
Sanofi SA.
Infinium Global Research

Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this
report provides insights on the factors that are driving and restraining the demand of biological drugs globally as well as
regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing
or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five
forces analysis and value chain analysis of biological drugs. Moreover, the study highlights current market trends and
provides forecast from 2017 to 2023. We also have highlighted future trends in the biological drugs market that will impact
the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on
the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key
players in the market. This report will help manufacturers, suppliers and distributors of the biological drugs market to
understand the present and future trends in this market and formulate their strategies accordingly.
Table of Contents:1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Biological Drugs Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
Infinium Global Research

3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.4 IGR – Growth Matrix Analysis
3.5 Competitive Landscape in the Biological Drugs Market
4. Global Biological Drugs Market Analysis, by Product Type 2017 – 2023
4.1 Protein Therapy
4.2 mAb Therapy
4.3 Vaccines
5. Global Biological Drugs Market Analysis, by Region 2017 – 2023
5.1 North America
5.1.1 North America Biological Drugs Market by Product
5.1.2 North America Biological Drugs Market by country
5.2 Europe
5.2.1 Europe Biological Drugs Market by Product
5.2.2 Europe Biological Drugs Market by country

Infinium Global Research

5.3 Asia-Pacific
5.3.1 Asia-Pacific Biological Drugs Market by Product
5.3.2 Asia-Pacific Biological Drugs Market by country
5.4 Rest of the World (RoW)
5.4.1 RoW Biological Drugs Market by Product
5.4.2 RoW Biological Drugs Market by Sub-region
6. Company Profiles
6.1 AbbVie Inc
6.2 Amgen Inc
6.3 Bristol-Myers Squibb
6.4 Biogen Idec
6.5 Hoffman-La Roche AG
6.6 Johnson & Johnson
6.7 Lilly
6.8 Merck & Co Inc
6.9 Novartis
6.10 Novo Nordisk
Infinium Global Research

6.11 Pfizer Inc
6.12 Sanofi SA
Click the Below Full Report Link:https://www.infiniumglobalresearch.com/healthcare_medical_devices/biological_drugs_market

Infinium Global Research


Related documents


biological drugs market
biosimilar market
blood cancer drugs market
pyrogen testing market
molecular modelling market
gastric cancer drugs market


Related keywords